Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy.
作者： Olle Karlstr??m , Filip Josephson , Anders S??nnerborg
DOI: 10.1097/QAI.0B013E31802E2940
关键词: Atazanavir 、 Maintenance therapy 、 Internal medicine 、 Gastroenterology 、 Regimen 、 Biomarker (medicine) 、 Bilirubin 、 Protease inhibitor (pharmacology) 、 Ritonavir 、 Medicine 、 Surgery 、 Viral load
摘要: … Our pilot trial of maintenance monotherapy was conducted using boosted atazanavir because it has the most favorable metabolic profile 12 among the approved boosted PIs and is …
lww.com
sci-hub.se 参考文章(16)
NI Berlin, PD Berk, Quantitative aspects of bilirubin metabolism for hematologists Blood. ,vol. 57, pp. 983- 999 ,(1981) , 10.1182/BLOOD.V57.6.983.BLOODJOURNAL576983
Kirk M Chan-Tack, Anthony Edozien, None, Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression. Journal of Acquired Immune Deficiency Syndromes. ,vol. 41, pp. 531- 532 ,(2006) , 10.1097/01.QAI.0000209902.89878.C9
Sarah MacManus, Phillip J Yates, Robert C Elston, Susan White, Naomi Richards, Wendy Snowden, GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients: absence of protease resistance at 48 weeks. AIDS. ,vol. 18, pp. 651- 655 ,(2004) , 10.1097/00002030-200403050-00009
Charles Hicks, Martin S King, Roy M Gulick, A Clinton White Jr, Joseph J Eron Jr, Harold A Kessler, Constance Benson, Kathryn R King, Robert L Murphy, Scott C Brun, Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. AIDS. ,vol. 18, pp. 775- 779 ,(2004) , 10.1097/00002030-200403260-00008
Jos?? R Arribas, Federico Pulido, Rafael Delgado, Alicia Lorenzo, Pilar Miralles, Alberto Arranz, Juan J Gonz??lez-Garc??a, Concepci??n Cepeda, Rafael Herv??s, Jos?? R Pa??o, Francisco Gaya, Antonio Carcas, Mar??a L Montes, Jos?? R Costa, Jos?? M Pe??a, Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). Journal of Acquired Immune Deficiency Syndromes. ,vol. 40, pp. 280- 287 ,(2005) , 10.1097/01.QAI.0000180077.59159.F4
Margaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, Jeffrey Coco, Edwin DeJesus, Adriano Lazzarin, Kenneth Lichtenstein, Victoria Wirtz, Anna Rightmire, Linda Odeshoo, Colin McLaren, 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures. AIDS. ,vol. 20, pp. 711- 718 ,(2006) , 10.1097/01.AIDS.0000216371.76689.63
Olle Karlström, Lars Ståhle, Luc Perrin, Heike Tegude, Anders Sönnerborg, Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patients. Scandinavian Journal of Infectious Diseases. ,vol. 38, pp. 371- 374 ,(2006) , 10.1080/00365540500469535
Kyle Petersen, Mark S Riddle, Lindsay E Jones, Kari J Furtek, Anne R Christensen, Sybil A Tasker, Braden R Hale, Use of bilirubin as a marker of adherence to atazanavir-based antiretroviral therapy. AIDS. ,vol. 19, pp. 1700- 1702 ,(2005) , 10.1097/01.AIDS.0000186826.60983.85
Robert L. Murphy, Scott Brun, Charles Hicks, Joseph J. Eron, Roy Gulick, Martin King, A. Clinton White, Constance Benson, Melanie Thompson, Harold A. Kessler, Scott Hammer, Richard Bertz, Ann Hsu, Anthony Japour, Eugene Sun, ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS. ,vol. 15, ,(2001) , 10.1097/00002030-200101050-00002
Christian Kahlert, Maria Hupfer, Thomas Wagels, Daniel Bueche, Walter Fierz, Ulrich A Walker, Pietro L Vernazza, Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection. AIDS. ,vol. 18, pp. 955- 957 ,(2004) , 10.1097/00002030-200404090-00017